HOME >> BIOLOGY >> NEWS
Advances in personalized medicine on agenda for 54th Society of Nucelar Medicine Annual Meeting

RESTON, Va. -- The potential of molecular imaging and therapy and the power of nuclear medicineand their impact on patient carewill be explored as more than 4,000 doctors, technologists, scientists and pharmacists from around the world attend SNMs 54th Annual Meeting June 26 in Washington, D.C. SNMan international, multidisciplinary society of more than 16,000 molecular imaging and nuclear medicine professionals in 78 countriesannually showcases research that promises to revolutionize health care.

"SNM has embarked on a mission to improve health care by advancing molecular imaging and therapy, and our program features an increased presence of related research," said SNM President Martin P. Sandler. "Molecular imagingthe use of state-of-the-art imaging technologies (such as PET, SPECT, MRI and others) to "photograph" biological targets or pathways in the bodyand its therapy value will be at the forefront of personalized medicine, eventually providing patient-specific information that allows tailored treatment of disease," he added.

"Nearly 2,000 scientific and technologist studies will be presented during this meeting, offering a look at molecular imaging and nuclear medicine research leading to improvements in the diagnosis and treatment of life-threatening cancer, heart disease and brain disorders," said Scientific Program Committee Chair Frederic H. Fahey. "A new feature this year is the InfoSNM program, which will allow attendees to participate in interactive computer presentations and educational offerings on the novel applications of computers and information science in molecular imaging and nuclear medicine," explained Fahey. Also new will be the Molecular Imaging Gateway, an area devoted specifically to this exciting field sponsored by the societys Molecular Imaging Center of Excellence.

"As molecular imaging becomes a significant force in clinical practice, SNM Technologist Section members will assume an expanded role in med
'"/>

Contact: Maryann Verrillo
mverrillo@snm.org
703-652-6773
Society of Nuclear Medicine
29-Mar-2007


Page: 1 2 3

Related biology news :

1. Advances in Optics for Biotechnology, Medicine and Surgery
2. Advances in Forest Threat Assessment: Applications to Forest and Rangeland Management
3. Advances in the characterisation of the oyster mushroom genes
4. ChemGenex reports successful personalized dosing of Quinamed at ASCO
5. Faster, low cost sequencing technologies needed to drive era of personalized medicine
6. Physicians face significant new liability risks with advent of personalized medicine era
7. Encouraging results from validation study of trial of personalized treatment in breast cancer
8. Computer graphics spills from milk to medicine
9. New survey documents the headaches of computerized medicine
10. Discoverer of Sly Syndrome finds way of delivering medicine to fight rare genetic disorder
11. Nanotechnology, medicine and bioethics

Post Your Comments:
(Date:4/23/2014)... term for novels and films which focus on the consequences ... how these fictions serve as a mental laboratory that allows ... imagine other living conditions. , "Global warming is much ... is also a cultural phenomenon in which meaning is being ... see. And there are so many of them now that ...
(Date:4/23/2014)... biomedical engineer at the University of Houston (UH) is ... transfusions safer. His work is supported by a $1.8 ... , Blood transfusions save millions of lives every ... Without them, for instance, routine surgeries would become life ... strong evidence that transfusions of red blood cells stored ...
(Date:4/22/2014)... to behave at the dinner tablecut up their food and ... Eating Behaviors , found that when 6-10 year old children ... such as drumsticks, whole apples, or corn on the cob ... cut. "They were twice as likely to disobey adults ... Professor and Director of the Cornell Food and Brand Lab. ...
Breaking Biology News(10 mins):Fiction prepares us for a world changed by global warming 2Fiction prepares us for a world changed by global warming 3UH biomedical engineer works to make blood transfusions safer 2UH biomedical engineer works to make blood transfusions safer 3Biting vs. chewing 2
(Date:1/14/2014)... Texas , Jan. 14, 2014 The ... and research medicinal plants and therapeutic derivatives thereof ... health professionals, and researchers about the challenges of ... http://photos.prnewswire.com/prnh/20100430/DC95601LOGO ) The Society ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility ... of Product Strategy. In this role, Michelle will work with ... guide in the development of iLab products. Her main goal ... benefit to the scientific community by offering the most advanced, ...
(Date:1/14/2014)... Mass. , Jan. 14, 2014  RXi Pharmaceuticals ... discovering, developing and commercializing innovative therapies addressing major ... that it received the Notice of Allowance from ... its unique self-delivering RNAi compounds (sd-rxRNA®), for the ...
(Date:1/14/2014)... Ontario , Jan. 14, 2014   Kinaxis ®, provider ... SCM ) and sales and operations planning ( S&OP ) ... Biomanufacturing Summit , which will be held at the ... the conference, join Kinaxis customer Elisabeth Kaszas , Director ...
Breaking Biology Technology:World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
Cached News: